Telephone-Based Re-education for Hp Eradication

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

162 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-10-18

Study Completion Date

2018-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It was suggested that the patient compliance plans an important role in the Hp eradication. However, data on whether re-education could improve the eradication rate are lacking. We consider that re-education on patients by telephone during the process of drug administration could increase the eradication rate in Hp infected patients.

We hypothesized that telephone re-education during the whole process of drug administration would improve the compliance of patients and ultimately increase the Hp eradication rate.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Treatment Adherence And Influencing Factors in Children With Helicobacter Pylori Infection During Eradication Therapy

NCT06396780

Helicobacter Pylori Infection Children, Only

ACTIVE_NOT_RECRUITING

Efficacy and Safety of Dual Therapy as First-line Treatment for Hp Infection

NCT05419674

Helicobacter Pylori Infection

UNKNOWN PHASE4

Eradication of H. Pylori Therapy Individualized by the Mutation of 23S rRNA of H. Pylori

NCT02761005

H. Pylori Infection

UNKNOWN PHASE2

Eradication Rates of Helicobacter Pylori and Its Affecting Factors

NCT01922505

Helicobacter Infections

COMPLETED

The Impact of Antibiotics MIC Value on the Efficacy of Treatment Regimens for Helicobacter Pylori Infection.

NCT03583476

Helicobacter Pylori Infection

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Helicobacter Pylori Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Re-education group

Patients in this arm will receive a repeated instruction by telephone in terms of both calling and message at the forth, seventh, tenth day after the start of treatment.

Group Type EXPERIMENTAL

telephone-based re-education

Intervention Type BEHAVIORAL

Patients will receive a repeated instruction by telephone in terms of both calling and message at the forth, seventh, tenth day after the start of treatment.

First education at the clinic

Intervention Type BEHAVIORAL

Patients will receive an instruction card about the drug administration at the clinic by doctors.

Non re-education group

Patients in this arm only received an instruction card about the drug administration at the clinic by doctors but no re-education by telephone during treatment

Group Type ACTIVE_COMPARATOR

First education at the clinic

Intervention Type BEHAVIORAL

Patients will receive an instruction card about the drug administration at the clinic by doctors.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

telephone-based re-education

Patients will receive a repeated instruction by telephone in terms of both calling and message at the forth, seventh, tenth day after the start of treatment.

Intervention Type BEHAVIORAL

First education at the clinic

Patients will receive an instruction card about the drug administration at the clinic by doctors.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Prior informed consent
2. 18-70 years of age
3. Hp infected patients diagnosed by 13C urea breath test, including digestive ulcer, gastritis with dyspepsia symptoms, family history of gastric cancer, planning to use long-term non-steroidal anti-inflammatory drugs (NSAIDs), or personal request
4. Ability to swallow oral medications
5. No contraindication for the drugs used for Hp eradication
6. Both men and women enrolled in this trial must use adequate barrier birth control during the course of the trial and 4 weeks after the completion of trial

Exclusion Criteria

1. Pregnant or breast-feeding subjects
2. Previous failed treatment of Hp eradication
3. Previous treatment with bismuth salts or antibiotics within 1 month before study enrollment, and treatment with proton pump inhibitor or H2 receptor antagonist within 2 weeks before study enrollment
4. Any disease that could jeopardize the safety of subject and their compliance in the study (e.g. serious liver disease, heart disease, kidney disease, malignant tumor or alcoholism, etc.)
5. Previous upper gastrointestinal surgery
6. Inability to express complaint (e.g. mental disorder, psychoneurosis, unable to cooperation, etc.)
7. Active clinically serious infections, except for Hepatitis B virus and hepatitis C virus infection
8. Clinically significant gastrointestinal bleeding within 4 weeks prior to start of study drug

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No